A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Minaprine
Pibrentasvir
The metabolism of Naloxone can be decreased when combined with Pibrentasvir.
Minaprine
Ertugliflozin
The metabolism of Naloxone can be decreased when combined with Ertugliflozin.
Minaprine
Silibinin
The metabolism of Naloxone can be decreased when combined with Silibinin.
Minaprine
Ombitasvir
The metabolism of Naloxone can be decreased when combined with Ombitasvir.
Minaprine
Sodium aurothiomalate
The metabolism of Naloxone can be decreased when combined with Sodium aurothiomalate.
Minaprine
Eltrombopag
The metabolism of Naloxone can be decreased when combined with Eltrombopag.
Minaprine
Deferasirox
The metabolism of Naloxone can be decreased when combined with Deferasirox.
Minaprine
Potassium cation
Naloxone may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Dapagliflozin
Dapagliflozin may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Canagliflozin
Naloxone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Efonidipine
Efonidipine may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Indapamide
Indapamide may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Mersalyl
Naloxone may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Potassium
Naloxone may increase the excretion rate of Potassium which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Bromotheophylline
Naloxone may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Epitizide
Naloxone may increase the excretion rate of Epitizide which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Xipamide
Naloxone may increase the excretion rate of Xipamide which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Muzolimine
Naloxone may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Clopamide
Naloxone may increase the excretion rate of Clopamide which could result in a lower serum level and potentially a reduction in efficacy.
Minaprine
Fenquizone
Naloxone may increase the excretion rate of Fenquizone which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3